WW International

WW

Market cap $220M

A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last

A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last

WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cautious Q4 guidance, which may keep investors wary until trends improve. Key catalysts ahead include FDA decisions on GLP-1 compounding, expanded insurance coverage, and new partnerships with pharma and insurance providers.

WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker.

WW International, Inc. ( WW ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants David Helderman - Director of Investor Relations Tara Comonte - President, CEO & Director Felicia DellaFortuna - Chief Financial Officer Jon Volkmann - Chief Operations Officer Conference Call Participants Alex Fuhrman - Lucid Capital Markets, LLC, Research Division Justin Ages - CJS Securities, Inc. Nathaniel Feather - Morgan Stanley, Research Division Presentation Operator Good morning, and welcome to WeightWatchers International's Third Quarter 2025 Results Conference Call. [Operator Instructions] Please note this event is being recorded.

End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand  Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss of $58 million; Net Loss Margin of 33.4%; Adjusted EBITDA 1 of $43 million and Adjusted EBITDA Margin 1 of 24.9% Narrowing 2025 Guidance to the higher end of previous ranges for Revenue and Adjusted EBITDA1 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the third quarter of fiscal 2025 ended September 30, 2025 2 in this Earnings Press Release and a Shareholder Letter posted on the Company's Corporate Website . Third Quarter 2025 Overview Q3 reflected a significantly strengthened balance sheet as the Company's first full quarter post-restructuring, with total debt reduced by more than 70% (~$1.1 billion) and Cash at quarter end increasing to $170 million from $152 million at the end of Q2.

WW International (WGHW 9.25%), owned of the storied Weight Watchers diet system, wasn't slimming down on Monday -- at least as far as its equity was concerned. The company's share price zoomed over 9% higher on the day, thanks in no small part to a deal it announced with a major e-commerce enterprise.